John D. Roberts

Active 1949–2024

83
Papers
22,074
Citations
75
h-index
80
i10-index

Citations

Citations per year for John D. Roberts1967: 1 citations1968: 5 citations1969: 1 citations1970: 6 citations1971: 4 citations1972: 7 citations1973: 14 citations1974: 21 citations1975: 8 citations1976: 15 citations1977: 7 citations1978: 5 citations1979: 6 citations1980: 11 citations1981: 13 citations1982: 5 citations1983: 14 citations1984: 20 citations1985: 14 citations1986: 23 citations1987: 34 citations1988: 50 citations1989: 130 citations1990: 157 citations1991: 212 citations1992: 246 citations1993: 223 citations1994: 232 citations1995: 189 citations1996: 176 citations1997: 180 citations1998: 158 citations1999: 131 citations2000: 100 citations2001: 91 citations2002: 101 citations2003: 76 citations2004: 65 citations2005: 62 citations2006: 59 citations2007: 55 citations2008: 49 citations2009: 65 citations2010: 68 citations2011: 40 citations2012: 62 citations2013: 57 citations2014: 48 citations2015: 32 citations2016: 33 citations2017: 61 citations2018: 58 citations2019: 177 citations2020: 175 citations2021: 181 citations2022: 123 citations2023: 78 citations2024: 141 citations2025: 70 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,381 citing papers, 46.7% of this breakdownUnited Kingdom: 346 citing papers, 6.8% of this breakdownCanada: 224 citing papers, 4.4% of this breakdownFrance: 203 citing papers, 4% of this breakdownGermany: 202 citing papers, 3.9% of this breakdownJapan: 198 citing papers, 3.9% of this breakdownChina: 162 citing papers, 3.2% of this breakdownItaly: 129 citing papers, 2.5% of this breakdownSwitzerland: 109 citing papers, 2.1% of this breakdownAustralia: 107 citing papers, 2.1% of this breakdownNetherlands: 95 citing papers, 1.9% of this breakdownSpain: 78 citing papers, 1.5% of this breakdown
0%46.7%Other 17%

Fields

  • Biochemistry, Genetics and Molecular Biology40.4%
  • Medicine30.7%
  • Immunology and Microbiology6.5%
  • Chemistry3.7%
  • Business, Management and Accounting3.5%
  • Agricultural and Biological Sciences3.4%
  • Other11.8%

Topics

  • RNA and protein synthesis mechanisms3.1%
  • DNA Repair Mechanisms2.6%
  • HIV Research and Treatment2.5%
  • Bacterial Genetics and Biotechnology2.3%
  • Hemoglobinopathies and Related Disorders2%
  • HIV/AIDS drug development and treatment1.9%
  • Other85.6%

Coauthors

All papers

Open in search
  1. Artificial intelligence and qualitative research: The promise and perils of large language model (LLM) ‘assistance’

    Authors: , , - Critical Perspectives on Accounting 2024 cited by 81

  2. An obesity-associated gut microbiome reprograms the intestinal epigenome and leads to altered colonic gene expression

    Authors: , , , , , , , - Genome biology 2018 cited by 167

  3. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases

    Authors: , , , , , , , , , , , , , , - JAMA 2017 cited by 357

  4. Daily Assessment of Pain in Adults with Sickle Cell Disease

    Authors: , , , , , , , , - Annals of Internal Medicine 2008 cited by 645

  5. Alterations in promoter interaction landscape and transcriptional network underlying metabolic adaptation to diet

    Authors: , , , , - Nature Communications 2020 cited by 70

  6. The Accuracy of Reverse Transcriptase from HIV-1

    Authors: , , - Science 1988 cited by 984

  7. Health related quality of life in sickle cell patients: The PiSCES project

    Authors: , , , , , , , - Health and Quality of Life Outcomes 2005 cited by 303

  8. Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects

    Authors: , , , , , , , , , , , , , , , , - Blood Advances 2020 cited by 122

  9. The CHD4-related syndrome: a comprehensive investigation of the clinical spectrum, genotype–phenotype correlations, and molecular basis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Līvija Medne, Bryan L. Krock, Cara Skraban, Elaine H. Zackai, Holly Dubbs, Thomas Smol, Jamal Ghoumid, Michael Parker, Michael Wright, Peter D. Turnpenny, Jill Clayton‐Smith, Kay Metcalfe, Hitoshi Kurumizaka, Bruce D. Gelb, Hagit Baris Feldman, Philippe M. Campeau, Maximilian Muenke, Paul A. Wade, Katherine Lachlan - Genetics in Medicine 2019 cited by 99

  10. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

    Authors: , , , , , , , , , , , , , , , , - Annals of Oncology 2015 cited by 93

  11. GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network

    Authors: , , , , , , , , , - Nature Communications 2018 cited by 115

  12. A phase I study of indoximod in patients with advanced malignancies

    Authors: , , , , , , , , , , , , , , , - Oncotarget 2016 cited by 144

  13. The possibilities of accountability

    Authors: - Accounting Organizations and Society 1991 cited by 782

  14. Heteroduplex repair in extracts of human HeLa cells

    Authors: , , - Journal of Biological Chemistry 1991 cited by 354

  15. REARRANGEMENT IN THE REACTION OF CHLOROBENZENE-1-C14 WITH POTASSIUM AMIDE1

    Authors: , , , - Journal of the American Chemical Society 1953 cited by 294

  16. Depression and Anxiety in Adults With Sickle Cell Disease: The PiSCES Project

    Authors: , , , , , , , , , - Psychosomatic Medicine 2007 cited by 260

  17. Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , - American Journal of Clinical Oncology 2019 cited by 41

  18. [19] Rapid and efficient site-specific mutagenesis without phenotypic selection

    Authors: , , - Methods in enzymology on CD-ROM/Methods in enzymology 1987 cited by 5,348

  19. RTOG 97-06: Initial report of a Phase I–II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy

    Authors: , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2003 cited by 202

  20. Understanding pain and improving management of sickle cell disease: the PiSCES study.

    Authors: , , , , , , , , - 2005 cited by 109

  21. Small-Ring Compounds. IV. Interconversion Reactions of Cyclobutyl, Cyclopropylcarbinyl and Allylcarbinyl Derivatives

    Authors: , - Journal of the American Chemical Society 1951 cited by 281

  22. The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.

    Authors: , , - Journal of Biological Chemistry 1992 cited by 142

  23. Pain site frequency and location in sickle cell disease: The PiSCES project

    Authors: , , , , , , , , - Pain 2009 cited by 123

  24. Vorinostat and Sorafenib Synergistically Kill Tumor Cells via FLIP Suppression and CD95 Activation

    Authors: , , , , , , , , , , , , , - Clinical Cancer Research 2008 cited by 114